Association of three factors (ABCB1 gene expression, steroid response, early response at day + 8) on the response to induction in patients with acute lymphoblastic leukemia
| Autor: | Juan Collazo-Jaloma, Adrián de la Cruz Rosas, Christian Omar Ramos-Peñafiel, Irma Olarte-Carrillo, Rafael Cerón Maldonado, Adolfo Martínez-Tovar |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Oncology
Adult Male Vincristine medicine.medical_specialty ATP Binding Cassette Transporter Subfamily B Time Factors Adolescent Daunorubicin Prednisolone Drug resistance Disease-Free Survival Persistence (computer science) 03 medical and health sciences 0302 clinical medicine Immunophenotyping Prednisone Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Humans Aged Retrospective Studies Hematology business.industry Gene Expression Regulation Leukemic Karyotype General Medicine Induction Chemotherapy Middle Aged Precursor Cell Lymphoblastic Leukemia-Lymphoma Neoplasm Proteins Survival Rate 030220 oncology & carcinogenesis Female business 030215 immunology medicine.drug |
| Zdroj: | Annals of hematology. 99(11) |
| ISSN: | 1432-0584 |
| Popis: | Treatment of acute lymphoblastic leukemia (ALL) requires the combination of multiple drugs to integrate a complete remission. The different prognostic factors (age, leukocytes, risk, cytogenetic alterations) allow identifying those patients with a high risk of relapse, but there are few described factors that impact the induction response. The objective was to identify the utility of different risk factors (overexpression of the ABCB1 drug resistance gene, favorable response to steroids (FRS) and early response at day + 8 of treatment) on the percentage of complete remissions and overall survival. This is a prospective, observational study in adult patients with B-ALL without specific cytogenetic alterations, who started induction treatment based on a pretreatment with prednisone and subsequently vincristine (1.6 mg/m2 subcutaneous) plus daunorubicin (45 mg/m2 subcutaneously) on days + 1, + 8, + 15. The ABCB1 resistance gene was evaluated at diagnosis, the FRS at the end of the pretreatment and the early response during day + 8. A total of 53 adult patients diagnosed with ALL Philadelphia negative chromosome (Ph-), with immunophenotype B, with a normal karyotype, were studied. Cases with genetic abnormalities with a poor prognosis were excluded in order to reduce bias. The mean age was 48 years (range 17-68 years). 62.3% of patients were at high risk of relapse. When analyzing the risk factors, 30.2% showed high levels of the ABCB1 resistance gene, without showing an impact on the induction response (OR: 1.218, p = 0.743), but its overexpression was associated with a poor response to steroids as in the absence of early response. Individually, both the FRS (OR: 5.7, p = 0.004) and the absence of early response to day + 8 (OR: 6.42, p = 0.002) showed significance. By combining the different factors, having more than 2 was directly related to a failure (OR: 9.514, p = 0.000). The identification of factors such as FRS such as the persistence of blasts at the end of the first week of treatment is useful to identify patients at risk of failure in induction. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink